Immune Biomarkers of Survival and Severe Infection in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with the Backbone Regimen Lenalidomide and Dexamethasone (Rd)

Immune Biomarkers of Survival and Severe Infection in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with the Backbone Regimen Lenalidomide and Dexamethasone (Rd)

Saved in:
Bibliographic Details
Published in:Blood Vol. 140; no. Supplement 1; pp. 4200 - 4203
Main Authors: Maia, Catarina, Puig, Noemi, Pérez Ruiz, Cristina, Cedena Romero, Maria Teresa, Guerrero, Camila, Larrayoz, Marta, Botta, Cirino, Gutierrez, Norma C., Calasanz, María José, Martin-Ramos, Maria Luisa, Hernández, Miguel, Rosinol Dachs, Laura, Garcia, Esther González, De Arriba, Felipe, Oriol, Albert, Gonzalez-Calle, Veronica, Escalante, Fernando, de la Rubia, Javier, Gironella Mesa, Mercedes, Rios, Rafael, Garcia Sanchez, Ricarda Belen, Arguiñano PEREZ, Jose Maria, Alegre, Adrian, Martin, Jesus, Couto Caro, María del Carmen, Casanova, Maria, Herraiz, Mario Arnao, Pérez, Ernesto, Garzón López, Sebastián, Gonzalez Perez, Marta Sonia, Martín-Nuñez, Guillermo, Rossi, Adriana, Coleman, Morton, Encinas, Cristina, Vale, Ana M., Teruel, Ana Isabel, Cortés Rodríguez, María, Martinez-Climent, Jose A., Lahuerta, Juan-José, Bladé Creixenti, Joan, Niesvizky, Ruben, San-Miguel, Jesús, Mateos, Maria-Victoria, Paiva, Bruno
Format: Journal Article
Language:English
Published: Elsevier Inc 15-11-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-163058